ArticleInternational journal of molecular sciences2023

Epigenomic Profiling Advises Therapeutic Potential of Leukotriene Receptor Inhibitors for a Subset of Triple-Negative Breast Tumors.

Alexey I Kalinkin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.